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Objective: To investigate the association between knee pain and signs of inﬂammation in the infrapa-
tellar fat pad (IPFP) in obese patients with knee osteoarthritis (KOA).
Design: In a cross-sectional setting, 3-T conventional contrast-enhanced (CE) magnetic resonance im-
aging (MRI) and dynamic contrast-enhanced (DCE)-MRI of KOA were analysed to quantify the extent of
inﬂammation in the IPFP, and correlated (Spearman's rank correlation) to pain and other symptoms
assessed via the Knee injury and Osteoarthritis Outcome Score (KOOS) (100 ¼ no pain, 0 ¼ extreme pain).
The extent of inﬂammation in the IPFP was assessed according to the MRI Osteoarthritis Knee Score
(MOAKS) using CE-MRI and by DCE-MRI perfusion variables. The perfusion variable, “Inﬂammation”, was
chosen as primary perfusion variable in the analysis. Intraclass correlation coefﬁcients for the perfusion
variables ranged from 0.81 to 0.99.
Results: MRI and clinical data were obtained in 95 patients. The typical patient was a woman (82%) with
an average age of 65 years (SD 6.5) and a body mass index (BMI) of 32 kg/m2 (SD 3.7). The bivariate
association between KOOS pain and the DCE-MRI perfusion variable “Inﬂammation” showed a statisti-
cally signiﬁcant correlation (r ¼ 0.42, P < 0.0001). A statistically signiﬁcant correlation was also found
between KOOS pain and MOAKS Hoffa-synovitis (r ¼ 0.21, P ¼ 0.046).
Conclusions: Perfusion variables on DCE-MRI reﬂecting the severity of inﬂammation in the IPFP and
MOAKS Hoffa-synovitis were associated with the severity of pain in KOA. These results suggest that
severe inﬂammation in the IPFP is associated with severe pain in KOA and that DCE-MRI is a promising
method to study the impact of inﬂammation in KOA.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.H. Bliddal, The Parker Insti-
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Pain is the most common symptom experienced by patients
with knee osteoarthritis (KOA)1. The exact aetiopathogenesis of
KOA, and especially of KOA pain, is unclear, but clinical, imaging
and biochemical observations indicate that inﬂammation may
contribute to both structural disease progression and pain2,3.
The infrapatellar fat pad (IPFP) is an intra-capsular, yet extra-
synovial, adipose structure in the anterior part of the knee joint
closely related to the articular cartilage, bone, and synovium2,4. The
IPFP contains adipocytes, macrophages, and immune cells capable
of producing inﬂammatory cytokines5, and several studies suggesttd. All rights reserved.
C. Ballegaard et al. / Osteoarthritis and Cartilage 22 (2014) 933e940934that inﬂammatory processes occur in the IPFP2,6,7. Additionally,
nociceptive nerve ﬁbres are present in the IPFP, and it has been
shown that inﬂammatory cytokines lower the threshold of such
joint nociceptors, inducing and worsening pain8,9. The potential
contribution of inﬂammation in the IPFP to the pain severity and
the pathophysiological changes in KOA is not clear10.
Magnetic resonance imaging (MRI) is widely used to assess the
joint pathology in studies of KOA. Usually, MRI of the joints is
performed without the use of intravenous (IV) Gadolinium (Gd)
contrast11. However, several studies have shown that the post-
contrast T1-weighted (T1w) sequence more accurately assess sy-
novitis compared with non-CE MRI12e14. In addition, when IV Gd
contrast is used, it provides the possibility to add a DCE-
MRI sequence to the MRI protocol. DCE-MRI has been used in
research and clinical practice for over two decades and it is a well-
known method for evaluating the behaviour of tissue perfusion in
different diseases and conditions, especially cancer15,16. DCE-MRI
has also been used to follow therapeutic response and disease
progression in inﬂammatory diseases such as rheumatoid arthritis
(RA)17e19, but few studies have investigated the use of DCE-MRI in
KOA14. DCE-MRI is a technique based on sequential acquisition of
rapid T1w MRI sequences of the same anatomy, before and during
the IV bolus infusion of Gd contrast20. Tissues with high perfusion
will take up Gd contrast rapidly and enhance to a larger extent and
more readily than tissues with low perfusion19. With appropriate
software, a signal intensity graph, i.e., the signal intensity increase
over time, can be generated for any given MRI-voxel21,22. Tissues
with high perfusion are likely to show early rapid increase on the
signal intensity graph, reach a plateau state and then potentially
show a relatively rapid decline (washout), whereas tissues with
lower perfusion show a slower increase and potentially no plateau
and washout phase within the ﬁrst 5 min after IV contrast
administration17,21. Various perfusion parameters, which charac-
terise the signal intensity graphs, can be extracted and used as
measures of hyperperfusion, the most important in previous
studies of musculoskeletal inﬂammatory joint pathologies being
the initial rate of enhancement (IRE), i.e., the speed of enhancement
or upslope on the signal intensity graph and the maximal
enhancement (ME), i.e., the highest intensity value17,19,22,23. The
potential association between hyperperfusion in the IPFP and pain
severity in KOA remains under examined10.
The aim of this study was, in a cross-sectional setting, to
investigate the association between pain and other knee-related
symptoms, assessed via the Knee injury and Osteoarthritis
Outcome Score (KOOS)24, and signs of inﬂammation in the IPFP,
assessed by conventional contrast-enhanced MRI (CE-MRI) using
the MOAKS (MRI Osteoarthritis Knee Score) score25, and by DCE-
MRI perfusion variables, derived from the Dynamika® software, in
a group of obese patients with KOA.
Method
Study population
All data except the radiographic data were from a weight-loss
maintenance study in obese patients with KOA e the “LIGHT
study” (ClinicalTrials.gov identiﬁer: NCT00938808). We included
all patients who complied with the recall at the 1-year visit in the
LIGHT study. The inclusion criterion for this study was participation
in a previous weight-loss study, the “CAROT study” (ClinicalTrials.
gov identiﬁer: NCT00655941), which included patients more than
50 years of age with a body mass index (BMI) 30 kg/m2, with
clinical KOA and veriﬁed radiographs26. The persons were not
included if any of the following criteria were present: lack of
motivation for weight reduction; insufﬁcient verbal or intellectualunderstanding; planned bariatric surgery; former or planned knee-
joint replacement; in pharmacologic treatment for obesity; medical
disease that prevents physical training; active joint disease besides
OA; signiﬁcant hip OA; use of morphine. No patients were excluded
due to their medical diseases. The local health research ethical
committee approved the LIGHT study and the procedures followed
were in accordance with the ethical standards of the committee
and the Helsinki Declaration of 1975, as revised in 2000. Written
and oral informed consent was obtained from each patient.
MRI protocol including dynamic MRI
MRI of the target knee, i.e., the most symptomatic knee, was
performed on a 3 T Siemens Verio® system. The patients were
scanned in the supine position using a dedicated 16-channel send/
receive knee coil. The following MRI protocol was used: knee
Gradient echo (GRE) scout (ST 8 mm, Field of View (FOV)
400  400 mm, TE 3.69 ms, TR 7.8 ms, scan time 17 s); coronal and
axial T1w turbo spin echo (TSE) (ST 3.5 mm, FOV 150  150 mm,
matrix resolution 0.6  0.5  3.5 mm, TE 17 ms, TR 790 ms, scan
time 2 min, 24 s); coronal and sagittal STIR (3 mm slices, FOV
160  160 mm, matrix resolution 0.7  0.6  3 mm, TI 220 ms, TE
34 ms, TR 4,350 ms, scan time 1 min 29 s); sagittal 3D PDw FS TSE
SPACE (ST isotropic 0.6 mm, FOV 160  160 mm, matrix resolution
0.6  0.5  0.6 mm, TE 44 ms, TR 1,000 ms, scan time 9 min 26 s);
sagittal GRE 3D T1w volumetric interpolated breath hold exami-
nation (VIBE) (ST 0.6 mm, FOV 160  160 mm, matrix resolution
0.6 0.6  0.6 mm, Flip angle (FA) 10, TE 5.39 ms, TR 11.6 ms, scan
time 3 min, 19 s).
Just prior to and simultaneously with the IV injection of 0.1 ml/
kg body weight Gd contrast (Prohance®, Bracco Diagnostics Inc.,
Italy) using a power injector (2 ml/s), a sequential axial DCE-MRI
GRE T1w VIBE sequence was performed in eighteen 5 mm slices
every 9 s, and with 30 repetitions using the following parameters:
TE 1.86, TR 5.51 FA 15, FOV 160 x 160, matrix resolution 192  138
(total scan time 4min, 40 s) covering the suprapatellar recess to the
insertion of the patella tendon on the tibia. Following this the static
3D GRE T1w sequence was repeated.
Image analysis
All MRI analyses were performed by investigators blinded to the
clinical data. DCE-MR images were analysed using the computer
software Dynamika® version 4.6 (Image Analysis LTD, London,
http://www.imageanalysis.org.uk)21,23. First, motion correction
between temporal slices was applied20. Then, CB manually drew a
region of interest (ROI) around the IPFP on all the DCE-MRI slices
from the apex of the patella to the insertion of the patellar tendon
on the tibia. As previously described in details19,23 for each voxel
within the ROI, signal intensity vs time curves were extracted and
automatically assigned and colour coded in a Gd-enhancement
map according to one of four statistically approximated patterns
of contrast uptake: (1) “no enhancement” (no colour), (2) “persis-
tent” (blue), (3) “plateau” (green) or (4) “washout” (red).
ME and IRE were automatically calculated and maps of IRE and
ME were generated, colour-coded and superimposed on the grey
scale dynamic images. The highest values for IRE and ME were
shown in bright yellow and lower values in a spectrum towards red
colours [Fig. 1, row C]. Using the Dynamika® software, the ROIs
were summed and averaged into a “VOI” (volume of interest) and
means of the perfusion variables for this VOI, and the total number
of voxels with plateau and washout pattern (N-plateau þ N-
washout), were automatically extracted.
Hoffa-synovitis was assessed by RR, supervised by MB, and
according to the MOAKS recommendations25, using the sagittal
Fig. 1. Hoffa-synovitis (MOAKS grades 0e3). Arrows encapsulate the enhancing lesions of various grades (A þ B). A and B. Sagittal and axial knee GRE T1-weighted (T1w) VIBE post-
contrast MRI. C. Axial DCE-MRI GRE T1w VIBE sequence. Changes in signal intensity after gadolinium injection are shown for the region of interest (ROI) encapsulating the IPFP.
Voxels are colour-coded for IRE.
C. Ballegaard et al. / Osteoarthritis and Cartilage 22 (2014) 933e940 935post-contrast 3D GRE T1w VIBE images. Fig. 1 shows examples of
the MRI. CB and RR performed inter- and intra-observer analyses
for the perfusion variables (ICC 0.81e0.99), and RR performed
intra-observer analysis for MOAKS Hoffa-synovitis (ICC 0.57), in
each case in 20 randomly selected subjects, with a minimum of 4
weeks between readings (Supplementary File 1).
Outcome measures
As speciﬁed in the statistical analysis plan, that is before theMRIs
were analysed, we decided to correlate the pain subscale of the
KOOS with the extent of inﬂammation in the IPFP assessed by the
DCE-MRI perfusionvariable “Inﬂammation”,S IRE (N-plateauþN-
washout). The following imaging variables were determined before
opening the database with clinical information: “Inﬂammation”, S
ME  (N-plateau þ N-washout), N-plateau þ N-washout, Inﬂam-
mation/volume, volume of the IPFP, and Hoffa-synovitis according
to the MOAKS17,18,22,25,27. MOAKS is a method for semi-
quantitatively scoring of KOA on MRI, and it is based upon the size
of the area with hyper-intensity in the IPFP (0 ¼ normal, 1 ¼ mild,
2 ¼ moderate, 3 ¼ severe)25. We used KellgreneLawrence (KL)
scores28 already obtained at the CAROT study. KOOS is a self-
administered patient-reported outcome (PRO) measure, assessing
ﬁve domains of importance to patients with KOA, including pain
(0¼ extremepain,100¼nopain)24. In this studyweused theDanish
validated version of the KOOS29,30. TheMRI and the KOOS datawere
obtained at the same time point. The KOOS data were stored in a
database, which was not opened until all MRIs were analysed.
Secondary laboratory clinimetrics included plasma levels of C-
reactive protein (CRP) and percentage of overall body fat mass. The
fat content was determined by dual energy X-ray absorptiometry(DXA). The measurements were carried out on a Lunar DPX IQ Full
Body Bone Densitometer (GE Medical Systems, Madison, WI, USA).
Secondary symptomatic measures used in the analyses were the
four following individual KOOS subscales: Symptoms, Function in
daily living (ADL), knee-related Quality of life (QOL), and Function
in sport and recreation (Sport/rec).
Statistical methods
All analyses were done by applying SAS software (v. 9.2 Service
Pack 4; SAS Institute Inc., Cary, NC, USA). Two-sided statistical
signiﬁcance tests were used; P-values <0.05 were considered
statistically signiﬁcant. The analyses were speciﬁed in the statis-
tical analysis plan and conducted on the ‘available case’ popula-
tion, i.e., no imputation for missing data (see Fig. 2): Spearman's
rank correlation was used in order to evaluate the potential
bivariate associations between the different variables to test
whether there was a statistically signiﬁcant correlation. Simple
linear regression models were performed to determine the asso-
ciations between KOOS pain and patient characteristics, including
DCE-MRI variables. Model#1 was KOOS pain vs the perfusion
variable “Inﬂammation” adjusted for the pre-speciﬁed covariates:
sex, age, and disease duration. Model#2 was KOOS pain vs the
perfusion variable “Inﬂammation” adjusted for the following
covariates: sex, age, disease duration, and percentage of overall
body fat mass. To assess the adequacy of the regression models,
describing the observed data e as well as checking the assump-
tions e we investigated the model features via the predicted
values and the studentized residuals; i.e., the residuals had to be
normally distributed (around zero), and be independent of the
predicted values.
Table I
Demographic, clinical, imaging variables, and KOOS-scores in 95 patients with KOA
Mean ± SD (minemax)
Demographic and clinical characteristics
Female, no. (%) 78 (82%)
Age (years) 65.3 ± 6.5 (52.4e77.4)
Disease duration (years)x 10.0 [5.5; 14.0] (3.0e22.0)
Height (cm) 165.9 ± 8.0 (148.0e189.0)
Weight (kg) 88.9 ± 12.5 (68.3e130.2)
BMI (kg/m2) 32.3 ± 3.7 (25.2e44.2)
CRP (mg/l)x* 2.0 [0.5; 4.0] (0.5e40.0)
DEXA scan
Fat Mass (kg) 37.4 ± 8.6 (19.7e66.0)
Fat Mass (%) 42.3 ± 6.6 (21.0e52.7)
KOOS scores
Pain 63.1 ± 17.5 (22.2e100.0)
Symptoms 64.5 ± 19.0 (10.7e100.0)
ADL 67.8 ± 17.2 (17.6e98.5)
QOL 45.3 ± 19.0 (6.3e93.8)
Sport/Recx 25.0 [15.0; 45.0] (0.0e95.0)
X-ray
KL score, no. (0-4)* 94
0, no. (%) 0 (0%)
1, no. (%) 10 (10.6%)
2, no. (%) 37 (39.4%)
3, no. (%) 38 (40.4%)
4, no. (%) 9 (9.6%)
MRI variables
Inﬂammationx 12.7 [4.9; 27.3] (0.09e132.2)
S ME x (N-plateau þ N-washout)x 3,618.4 [1,950.0; 5,872.8]
(36.8e25,038.9)
N-plateau þ N-washoutx 2,383.0 [1,590.0; 3,427.0]
(31.0e12,232.0)
Inﬂammation/volumex 0.43 [0.22; 0.89] (0.005e4.0)
Volume of the IPFP (ml)x 27.4 [22.6; 31.9] (16.2e62.9)
MOAKS Hoffa-synovitis (0e3)x 2 [1; 2] (0e3)
Except where indicated otherwise, values are mean ± SD (minemax); x showed a
non-Gaussian distribution, thus, presented as median [interquartile range] (min-
emax). *Data from 94 patients. Abbreviations: ADL, Function in daily living; QOL,
Knee related Quality of life; Sport/Rec, Function in sport and recreation; KL, Kell-
greneLawrence; Inﬂammation, S IRE  (N-plateau þ N-washout); Inﬂammation/
volume, S IRE (N-plateauþN-washout) divided by the volume of the infrapatellar
fat pad.
Fig. 2. Trial proﬁle.
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Patient characteristics
In this cross-sectional study, we included all 134 patients who
complied with the recall at the 1-year visit in the LIGHT study. Due
to one of the two following reasons, 37 patients failed to complete
the MRI analysis: (1) the target knee was >53 cm in circumference
and could therefore not ﬁt into the MRI-coil, or (2) the patient had
an estimated glomerular ﬁltration rate (eGFR) <60 ml/min/1.73 m2,
and according to The Danish Health and Medicines Authority31, the
administration of IV contrast medium is then contra-indicated. This
resulted in MRI in 97 patients. During the analysis period, technical
difﬁculties with two data sets prevented valid image analysis. The
number of analysed MRI data sets was therefore 95 (70% of the
study population) [Fig. 2]. The typical patient participating in this
study was a 65-year-old woman with a BMI of 32 kg/m2. Patient
characteristics are shown in Table I. The 95 patients who completed
the MRI had statistically signiﬁcantly lower levels of CRP, weight,
BMI, fat mass, and percentage of overall body fat mass compared
with the 39 patients who failed to complete the MRI
(Supplementary File 2).
Outcomes
The bivariate correlation (Spearman’s rank correlation) showed
a statistically signiﬁcant association between KOOS pain and the
perfusion variable, “Inﬂammation” (r ¼ 0.42, P < 0.0001), and
between KOOS pain and MOAKS Hoffa-synovitis (r ¼ 0.21,
P ¼ 0.046) (Table II and Fig. 3).
The simple linear regression model showed a statistically sig-
niﬁcant association between KOOS pain and the DCE-MRI perfusion
variable “Inﬂammation” (Slope¼0.34 (0.48;0.20), P< 0.0001).
Adjustment for sex, age, disease duration, and percentage of overall
body fat mass did not change the signiﬁcance of the result
(Table III).
Discussion
In this study we correlated patient related outcome measures
with signal intensity changes in the IPFP using DCE-MRI and CE-
MRI. In obese patients with KOA we found statistically signiﬁcant
associations between pain, assessed by the pain subscale of the
KOOS questionnaire, and perfusion variables on DCE-MRI repre-
senting inﬂammation in the IPFP. This means that severeinﬂammation in the IPFP was associated with severe pain. We also
found statistically signiﬁcant correlations between MOAKS Hoffa-
synovitis and KOOS pain and between MOAKS Hoffa-synovitis
and all perfusion variables.
Our results lend further support to the notion of inﬂammation in
the IPFP as a contributor to pain in KOA. In a previous study,
increasing inﬂammatory changes in the IPFP assessed by MRI was
correlated to increase in pain, while no direct relationship was
observed at baseline32. Our patients had the same BMI (32.3 vs
31.5) as the former study. However, our patients were tested 2 years
into aweight loss program andmay have been considerably heavier
previously. Also, our study population consisted of mainly female
participants in contrast to the other study with 58.5% males. Thus,
the present study group may have been more representative of the
typical KOA patient, at least in Denmark. The present ﬁndings of a
direct association in a cross-sectional material are substantiated by
the parallel increases in MOAKS and DCE-MRI.
Biopsies from the infrapatellar region in patients with KOA have
shown chronic low-grade inﬂammation, detectable as signal
changes on ﬂuid-sensitive MRI sequences33. The IPFP is richly
innervated with nociceptive nerve ﬁbres, and the sensitization of
these nociceptors caused by inﬂammation may underlie pain and
hyperalgesia in the inﬂamed joint9. Studies investigating other
knee joint diseases and injuries have found similar associations
between pain and cellular changes in the IPFP34,35, and knee pain
can be mimicked by injection of hypertonic saline into the IPFP36. It
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Fig. 3. Correlation between pain assessed by the KOOS subscale pain and the perfusion
variable, “Inﬂammation”, S IRE  (N-plateau þ N-washout).
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represent inﬂammation within the IPFP itself or reﬂect inﬂamma-
tory activity in neighbouring proliferating synovium5,13,25,33.
Concordant with previous studies37,38, this study showed a
statistically signiﬁcant association between the percentage of
overall body fat mass and the concentration of plasma CRP, sug-
gesting that patients with a larger fat mass have higher levels of
systemic inﬂammation. We also found a statistically signiﬁcant
correlation between pain and the volume of the IPFP, indicating
that the size of the IPFP might be determinant for pain severity.
However, the two variables volume and “Inﬂammation” might
express different aspects of the IPFP. It has been suggested that the
volume of the IPFP increases with i.e., age10 and, thus, may not be
related to increased perfusion/inﬂammation, as are the perfusion
measures.
Although MOAKS Hoffa-synovitis, as well as the perfusion var-
iables, was signiﬁcantly associated with pain, the perfusion vari-
ables showed stronger correlations with pain than the MOAKS
score. This may be due to the fact that MOAKS Hoffa-synovitis is a
semi-quantitative score, while the dynamic perfusion variables are
continuous variables. The perfusion variable “Inﬂammation”
showed a good association not only with pain, but also with all
subscales of the KOOS, suggesting an association between
increased perfusion both more severe pain, and more severe knee-
related symptoms and impaired function in daily living, knee-
related QOL and function in sport and recreation. In addition, in
knee RA it was previously shown that “Inﬂammation” is the
perfusion variable most sensitive to changes in the synovium after
treatment with intraarticular steroid17. A potentially appealing
rationale for future use would be to consider this as a biomarker in
trials of inﬂammation in KOA.
In the last two decades, hyperperfusion derived from DCE-MRI
data has become a more widely used method for diagnosis and
monitoring of inﬂammatory joint diseases39,40. In RA, DCE-MRI can
discriminate active from inactive disease18, and it is useful in
assessing the response to inﬂammatory suppression therapy41.
Histological signs of inﬂammation in the synovium correlate with
perfusion variables assessed by DCE-MRI in RA, especially the IRE22.
Table III
Regression analysis (KOOS pain is the dependent variable)
Independent variables Simple linear regression models Model 1 Model 2
R2 ¼ 25.8% R2 ¼ 26.6%
Inﬂammation 0.34 (0.48; 0.20); <0.0001; 18.8% 0.35 (0.49; 0.21); <0.0001 0.33 (0.48; 0.18); <0.0001
S ME  (N-plateau þ N-washout) 0.0024 (0.0033; 0.0015); <0.0001; 22.0%
N-plateau þ N-washout 0.0047 (0.0066; 0.0028); <0.0001; 21.0%
Inﬂammation/volume 10.79 (15.87; 5.71); <0.0001; 15.7%
KL score (0e4)* 7.20 (11.37; 3.03); 0.001; 11.0%
MOAKS Hoffa-synovitis (0e3) 6.53 (12.37; 0.69); 0.03; 4.9%
Age (years) 0.087 (0.46; 0.64); 0.76; 0.10% 0.14 (0.35; 0.63); 0.57 0.095 (0.40; 0.59); 0.71
Sex (1 ¼ Female; 0 ¼ Male) 4.65 (4.54; 13.84); 0.32; 1.0% 2.88 (5.37; 11.13); 0.50 6.90 (4.66; 18.46); 0.25
Disease duration (years) 0.66 (1.23; 0.09); 0.025; 5.3% 0.74 (1.25; 0.23); 0.006 0.69 (1.22; 0.16); 0.01
Fat mass (%) 26.83 (80.38; 26.72); 0.33; 1.0% 33.54 (101.08; 34.00); 0.33
Values are: slope (95% CI); P-value; R2. Model#1: KOOS pain vs “Inﬂammation” adjusted for pre-speciﬁed covariates: Sex, age, disease duration. Model#2: KOOS pain vs
“Inﬂammation” adjusted for sex, age, disease duration, and percentage of overall body fat mass. Data are from 95 subjects, unless speciﬁed. *Data from 94 subjects. Abbre-
viations: Inﬂammation, S IRE (N-plateau þ N-washout); Inﬂammation/volume, S IRE (N-plateau þ N-washout) divided by the volume of the infrapatellar fat pad.
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as in the case of RA. However, one study has shown that the speed of
contrast uptake in synovial tissue is associatedwithmicroscopically
graded synovitis inmoderate to severe KOA14, which alongwith our
results underline the potential of using the DCE-MRI to study the
signiﬁcance of inﬂammation in KOA. It is important to emphasize,
though, that hyperperfusion derived from DCE-MRI data is not only
related to inﬂammatory disease, but has been widely used to
describe perfusion in a large range of both benign and malignant
conditions42.
The major strength of this study was its size with thorough
clinical and imaging data collected from obese patients with KOA.
Furthermore, the combination of a 3 T MRI scanner and the use of
Gd contrast lead to excellent image quality and thereby the best
possibilities for image analysis. The analyses showed high intraclass
correlation coefﬁcients in the same range as previously published
studies using both MOAKS and Dynamika® derived DCE-MRI
analysis17,20,25. Hence, the DCE-MRI analysis method was robust
and reproducible.
This study has potential limitations. A relatively large part of the
patients failed to complete the MRI and these patients had statis-
tically signiﬁcantly higher levels of CRP, weight, BMI, fat mass, and
percentage of overall body fat mass compared with the patients
who completed the MRI. This may have resulted in a selection bias.
Furthermore, the cross-sectional design precluded an evaluation of
causal relationship between pain and MRI, and we could not
evaluate the inﬂuence of weight-loss and other potential temporal
factors. Pain in KOA have been shown to be associated with a
number of other joint pathologies such as bone marrow lesions,
synovitis/effusion, meniscal pathology, popliteal cysts, etc43e45. In
this study, we focused on the role of the IPFP in KOA pain, but we
did not look at other potential causes for pain in KOA.
In conclusion, the study showed that MOAKS Hoffa-synovitis,
and to a larger extent the perfusion variables from DCE-MRI indi-
cating inﬂammation in the IPFP,were related topain anddisability in
obese patients with KOA. These results suggest that severe inﬂam-
mation in the IPFP is associated with severe pain in KOA and that
DCE-MRI, analysedwith a standardized andwell-validated software
program21,46, is feasible and reproducible and has potential to be
used to study the impact of inﬂammation in KOA. However, longi-
tudinal studies are needed for a further clariﬁcation of the use of the
presentDCE-MRI technique and for a further examination of the role
of the IPFP in the aetiopathogenesis of KOA.
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